Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;2(4):100177.
doi: 10.1016/j.ajogmf.2020.100177. Epub 2020 Jul 15.

Early lessons from maternal mortality review committees on drug-related deaths-time for obstetrical providers to take the lead in addressing addiction

Affiliations

Early lessons from maternal mortality review committees on drug-related deaths-time for obstetrical providers to take the lead in addressing addiction

Marcela C Smid et al. Am J Obstet Gynecol MFM. 2020 Nov.

Abstract

Problem:: In the United States, maternal mortality review committees (MMRC) are providing compelling data that drug-related deaths are emerging as a leading cause of pregnancy-associated death (death during pregnancy or up to a year postpartum). Recommendations from the MMRC consistently highlight screening all pregnant and postpartum women for drug use and improving access to evidence-based substance use disorder and mental health treatment. Unfortunately, many providers lack the confidence, skills and necessary resources to screen for substance use, provide basic behavioral health services or facilitate referral to high-quality services in their clinical settings. Our profession’s collective lack of response to a leading cause of maternal death represents a missed opportunity for potentially life-saving interventions.

A Solution:: We call on our fellow obstetrician gynecologists to incorporate the lessons learned from MMRC and integrate addiction assessment and treatment into prenatal and postpartum care. Provider level integration of behavioral health services is, however, insufficient to fully address the magnitude of drug-related maternal deaths in the US. We, therefore, ask colleagues to address the structural/systemic barriers to care identified in MMRC. By doing so, we can prevent drug-related maternal deaths.

PubMed Disclaimer

References

    1. HAIGHT SC, KO JY, TONG VT, BOHM MK, CALLAGHAN WM. Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999–2014. MMWR Morb Mortal Wkly Rep 2018;67:845–49. - PMC - PubMed
    1. CENTERS FOR DISEASE CONTROL AND PREVENTION. 2018 Annual Surveillance Report of Drug-Related Risks and Outcomes —United States Surveillance Special Report. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; Published August 31, 2018. Accessed February 13th, 2020 from https://www.cdc.gov/drugoverdose/pdf/pubs/2018-cdc-drug-surveillance-rep...
    1. PIERRE AS, ZAHARATOS J, GOODMAN D, CALLAGHAN WM. Challenges and opportunities in identifying, reviewing, and preventing maternal deaths. Obstet Gynecol 2018;131:138. - PMC - PubMed
    1. HAIGHT SC. Opioid Use Disorder Documented at Delivery Hospitalization—United States, 1999–2014. MMWR Morbidity and mortality weekly report 2018;67. - PMC - PubMed
    1. GEMMILL A, KIANG MV, ALEXANDER MJ. Trends in pregnancy-associated mortality involving opioids in the United States, 2007–2016. Am J Obstet Gynecol 2019;220:115–16. - PubMed

Substances